Annual EBITDA:
$395.90M+$12.40M(+3.23%)Summary
- As of today, ACA annual EBITDA is $395.90 million, with the most recent change of +$12.40 million (+3.23%) on December 31, 2024.
- During the last 3 years, ACA annual EBITDA has risen by +$144.60 million (+57.54%).
- ACA annual EBITDA is now -21.03% below its all-time high of $501.30 million, reached on December 31, 2022.
Performance
ACA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$165.90M+$16.70M(+11.19%)Summary
- As of today, ACA quarterly EBITDA is $165.90 million, with the most recent change of +$16.70 million (+11.19%) on September 30, 2025.
- Over the past year, ACA quarterly EBITDA has increased by +$66.40 million (+66.73%).
- ACA quarterly EBITDA is now at all-time high.
Performance
ACA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$546.20M+$66.40M(+13.84%)Summary
- As of today, ACA TTM EBITDA is $546.20 million, with the most recent change of +$66.40 million (+13.84%) on September 30, 2025.
- Over the past year, ACA TTM EBITDA has increased by +$175.20 million (+47.22%).
- ACA TTM EBITDA is now at all-time high.
Performance
ACA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +3.2% | +66.7% | +47.2% |
| 3Y3 Years | +57.5% | +87.3% | +74.2% |
| 5Y5 Years | +65.4% | +136.0% | +101.5% |
ACA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -21.0% | +57.5% | at high | +194.7% | at high | +74.2% |
| 5Y | 5-Year | -21.0% | +65.4% | at high | +205.5% | at high | +120.2% |
| All-Time | All-Time | -21.0% | +142.1% | at high | +272.0% | at high | +882.4% |
ACA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $165.90M(+11.2%) | $546.20M(+13.8%) |
| Jun 2025 | - | $149.20M(+41.7%) | $479.80M(+10.1%) |
| Mar 2025 | - | $105.30M(-16.3%) | $435.70M(+4.8%) |
| Dec 2024 | $395.90M(+3.2%) | $125.80M(+26.4%) | $415.70M(+12.0%) |
| Sep 2024 | - | $99.50M(-5.3%) | $371.00M(+3.7%) |
| Jun 2024 | - | $105.10M(+23.2%) | $357.80M(+4.4%) |
| Mar 2024 | - | $85.30M(+5.2%) | $342.60M(+0.1%) |
| Dec 2023 | $383.50M(-23.5%) | $81.10M(-6.0%) | $342.20M(+7.8%) |
| Sep 2023 | - | $86.30M(-4.0%) | $317.40M(-0.7%) |
| Jun 2023 | - | $89.90M(+5.9%) | $319.70M(-2.1%) |
| Mar 2023 | - | $84.90M(+50.8%) | $326.50M(+3.9%) |
| Dec 2022 | $501.30M(+99.5%) | $56.30M(-36.5%) | $314.10M(+0.2%) |
| Sep 2022 | - | $88.60M(-8.4%) | $313.60M(+4.0%) |
| Jun 2022 | - | $96.70M(+33.4%) | $301.50M(+10.6%) |
| Mar 2022 | - | $72.50M(+29.9%) | $272.70M(+7.2%) |
| Dec 2021 | $251.30M | $55.80M(-27.1%) | $254.50M(+0.1%) |
| Sep 2021 | - | $76.50M(+12.7%) | $254.20M(+2.5%) |
| Jun 2021 | - | $67.90M(+25.0%) | $248.00M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $54.30M(-2.2%) | $255.80M(-6.4%) |
| Dec 2020 | $263.30M(+10.0%) | $55.50M(-21.1%) | $273.40M(+0.9%) |
| Sep 2020 | - | $70.30M(-7.1%) | $271.00M(+2.2%) |
| Jun 2020 | - | $75.70M(+5.3%) | $265.20M(+4.6%) |
| Mar 2020 | - | $71.90M(+35.4%) | $253.50M(+6.2%) |
| Dec 2019 | $239.40M(+46.4%) | $53.10M(-17.7%) | $238.70M(+3.7%) |
| Sep 2019 | - | $64.50M(+0.8%) | $230.20M(+8.5%) |
| Jun 2019 | - | $64.00M(+12.1%) | $212.10M(+9.0%) |
| Mar 2019 | - | $57.10M(+28.0%) | $194.50M(+4.7%) |
| Dec 2018 | $163.50M(-16.5%) | $44.60M(-3.9%) | $185.70M(+31.6%) |
| Sep 2018 | - | $46.40M(0.0%) | $141.10M(-2.8%) |
| Jun 2018 | - | $46.40M(-3.9%) | $145.10M(-2.9%) |
| Mar 2018 | - | $48.30M(-4.2%) | $149.50M(-4.7%) |
| Dec 2017 | $195.80M(-25.5%) | - | - |
| Sep 2017 | - | $50.40M(-0.8%) | $156.80M(+47.4%) |
| Jun 2017 | - | $50.80M(-8.6%) | $106.40M(+91.4%) |
| Mar 2017 | - | $55.60M | $55.60M |
| Dec 2016 | $262.80M(-8.6%) | - | - |
| Dec 2015 | $287.40M | - | - |
FAQ
- What is Arcosa, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Arcosa, Inc.?
- What is Arcosa, Inc. annual EBITDA year-on-year change?
- What is Arcosa, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Arcosa, Inc.?
- What is Arcosa, Inc. quarterly EBITDA year-on-year change?
- What is Arcosa, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Arcosa, Inc.?
- What is Arcosa, Inc. TTM EBITDA year-on-year change?
What is Arcosa, Inc. annual EBITDA?
The current annual EBITDA of ACA is $395.90M
What is the all-time high annual EBITDA for Arcosa, Inc.?
Arcosa, Inc. all-time high annual EBITDA is $501.30M
What is Arcosa, Inc. annual EBITDA year-on-year change?
Over the past year, ACA annual EBITDA has changed by +$12.40M (+3.23%)
What is Arcosa, Inc. quarterly EBITDA?
The current quarterly EBITDA of ACA is $165.90M
What is the all-time high quarterly EBITDA for Arcosa, Inc.?
Arcosa, Inc. all-time high quarterly EBITDA is $165.90M
What is Arcosa, Inc. quarterly EBITDA year-on-year change?
Over the past year, ACA quarterly EBITDA has changed by +$66.40M (+66.73%)
What is Arcosa, Inc. TTM EBITDA?
The current TTM EBITDA of ACA is $546.20M
What is the all-time high TTM EBITDA for Arcosa, Inc.?
Arcosa, Inc. all-time high TTM EBITDA is $546.20M
What is Arcosa, Inc. TTM EBITDA year-on-year change?
Over the past year, ACA TTM EBITDA has changed by +$175.20M (+47.22%)